FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Chantix Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Pfizers smoking cessation drug Chantix (varenicline tartrate) tablets, 0.5 mg and 1 mg, have not been wit...

latest-news-card-1
Human Drugs

Lawsuit Seeks REMS Removal on Mifepristone

A multistate lawsuit seeks FDAs removal of REMS restrictions on medical abortion drug mifepristone.

latest-news-card-1
Biologics

Pfizer/BioNTech sBLA for Harmonized Covid Shot

Adhering to an FDA advisory committee recommendation last month, Pfizer and BioNTech file a supplemental BLA that seeks approval of their Omicron BA.4...

latest-news-card-1
FDA General

Panel to Vote on Converting Paxlovid EUA to Traditional Approval

A Pfizer NDA seeking traditional approval for its Covid-19 drug Paxlovid (nirmatrelvir and ritonavir co-packaged tablets) heads to a 3/16 Antimicrobia...

latest-news-card-1
Human Drugs

Guide on Wet Age Macular Degeneration Drugs

FDA posts a draft guidance on wet age-related macular degeneration drug development.

latest-news-card-1
EIRS/483s

Califf Pushes Improved Evidence Generation System

FDA commissioner Robert Califf calls for better evidence generation and suggests that with the rapidly advancing artificial intelligence (AI) space (e...

latest-news-card-1
Medical Devices

Human Factor Guidance is FDA Mission Creep: Attorney

Attorney Jeffrey Shapiro says FDA is using a new draft guidance to significantly expand the instances when human factors data must be part of a 510(k)...

Human Drugs

Octapharma Submits Wilate sBLA

Octapharma USA submits an sBLA for an expanded indication for its Wilate von Willebrand disease bleeding control drug.

latest-news-card-1
Human Drugs

PhRMA Proposes Changes to M11 Guidance

PhRMA gives FDA specific comments and edits on the International Council for Harmonization M11 protocol. Template, and technical specification.

latest-news-card-1
Human Drugs

CMS Continues Block on Alzheimers Drug Coverage

The Centers for Medicare & Medicaid Services says it is not reconsidering its national coverage determination that restricts Medicare coverage on Alzh...